+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pediatrics Pneumococcal Therapeutics Market - Global Forecast 2026-2032- Product Image
Pediatrics Pneumococcal Therapeutics Market - Global Forecast 2026-2032- Product Image
Sale

Pediatrics Pneumococcal Therapeutics Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6055447
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pediatrics Pneumococcal Therapeutics Market is projected to reach USD 20.01 Billion in 2026. It is expected to continue growing at a CAGR of 8.40%, reaching USD 32.58 Billion by 2032.

Pediatric Pneumococcal Therapeutics: Executive Overview

Pediatric pneumococcal therapeutics address the prevention and treatment of infections caused by Streptococcus pneumoniae, including pneumonia, meningitis, bacteremia, otitis media, and sinusitis. Clinical priorities center on rapid recognition of invasive disease, appropriate antimicrobial selection, management of complications, and prevention through immunization. The field is shaped by childhood vaccination policies, antimicrobial-resistance surveillance, access to pediatric formulations, and the capacity of health systems to deliver timely care.

How Vaccination, Resistance, and Care Pathways Are Reshaping Practice

The landscape is shifting from treatment centered solely on acute infection toward integrated prevention and stewardship. Routine pneumococcal conjugate vaccination has reduced disease caused by vaccine-covered serotypes in many settings, while replacement by non-vaccine serotypes and uneven coverage sustain the need for surveillance. Resistance patterns increasingly influence empiric therapy, making local susceptibility data, age-specific dosing, diagnostic testing, and escalation or de-escalation protocols essential. Hospital and community pathways are also placing greater emphasis on early referral for suspected invasive disease and follow-up for children with complications or recurrent infections.

Artificial Intelligence Strengthens Diagnosis, Surveillance, and Stewardship

Artificial intelligence can support pediatric pneumococcal care by identifying high-risk presentations in clinical records, assisting radiographic or laboratory interpretation, and linking microbiology results with resistance trends. Predictive tools may help prioritize testing, flag deterioration, and improve antimicrobial stewardship when integrated with clinician review and validated against pediatric populations. Its cumulative value depends on representative data, transparent performance measures, privacy safeguards, and interoperability across hospitals, laboratories, immunization registries, and public-health systems. AI should augment rather than replace clinical judgment, particularly where symptoms overlap with viral disease or other bacterial infections.

Regional Priorities Differ Across North America, Latin America, Europe, Middle East, Africa, and Asia-Pacific

North America generally emphasizes high routine immunization coverage, resistance monitoring, pediatric stewardship, and management of breakthrough disease. Latin America continues to prioritize equitable vaccine access, laboratory capacity, and consistent treatment pathways across urban and rural settings. Europe combines established immunization programs with surveillance of serotype distribution, antimicrobial resistance, and cross-border variation in policy. The Middle East faces differing health-system capacities, population mobility, and continuity-of-care requirements. Africa’s priorities include strengthening vaccination delivery, oxygen and hospital capacity, diagnostics, and referral systems for severe pneumonia and invasive disease. Asia-Pacific spans highly diverse epidemiology and resources, creating demand for locally adapted vaccination strategies, laboratory networks, pediatric formulations, and surveillance that captures both densely populated urban areas and remote communities.

Cross-Group Priorities Across ASEAN, BRICS, the European Union, G7, GCC, and NATO

ASEAN members benefit from coordinated surveillance, procurement dialogue, and approaches suited to densely populated and geographically dispersed communities. BRICS countries have substantial opportunities to align research, manufacturing, resistance monitoring, and access initiatives while accounting for major differences in health-system organization. The European Union can build on shared surveillance and regulatory cooperation to improve comparability of serotype and resistance data. G7 members can advance pediatric stewardship, diagnostic standards, and support for global immunization and research infrastructure. GCC countries can emphasize continuity of pediatric services for mobile populations and harmonized clinical guidance. NATO members can strengthen preparedness for health emergencies by incorporating pneumococcal prevention, pediatric treatment capacity, and supply-chain resilience into broader medical readiness planning.

Country-Level Considerations for Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Russia, South Korea, Spain, the UK, and the US

Australia and Canada can continue integrating vaccination policy with Indigenous, rural, and remote-community health priorities. Brazil, Mexico, and India require sustained attention to equitable immunization, timely diagnosis, pediatric referral, and resistance surveillance across varied levels of care. China, Japan, and South Korea can pair strong clinical infrastructure with monitoring of serotype change, vaccine-policy effectiveness, and antimicrobial use. France, Germany, Italy, and Spain can focus on harmonized surveillance, stewardship, and management of variation in regional immunization delivery. The United Kingdom can continue linking national guidance with surveillance and rapid pediatric referral. The United States can emphasize breakthrough disease monitoring, equitable coverage, and coordination between outpatient, emergency, inpatient, and public-health services. Russia’s priorities include resilient supply, regionally representative surveillance, and consistent access to pediatric diagnostics and treatment.

Actions Leaders Can Take to Improve Pediatric Pneumococcal Outcomes

Industry and health-system leaders should align prevention, diagnosis, and treatment around measurable pediatric outcomes. Priority actions include maintaining age-appropriate immunization programs; expanding serotype and resistance surveillance; securing reliable supplies of pediatric formulations, diagnostics, and supportive-care equipment; standardizing empiric-treatment and de-escalation pathways; and improving referral protocols for suspected invasive disease. Leaders should also invest in clinician education, caregiver communication, post-discharge follow-up, and data systems that connect laboratories, hospitals, pharmacies, and public-health agencies. AI initiatives should begin with clearly defined clinical uses, pediatric validation, bias monitoring, and human oversight.

Methodology for a Reliable Executive Assessment

This executive summary uses a structured, evidence-led review framework for pediatric pneumococcal therapeutics. It considers disease burden drivers, vaccination policy, serotype evolution, antimicrobial resistance, diagnostic and treatment pathways, health-system capacity, access conditions, and regional policy variation. Interpretation should be grounded in authoritative clinical guidelines, immunization schedules, peer-reviewed pediatric studies, microbiology surveillance, public-health reports, and regulatory documentation. Findings should be stratified by age, disease severity, geography, vaccine history, and care setting, with uncertainty stated where evidence is incomplete. No market estimates, market shares, forecasts, or company-specific claims are used.

Conclusion: Integrated Prevention and Treatment Will Define Progress

Pediatric pneumococcal therapeutics are increasingly governed by the interaction of vaccination, antimicrobial stewardship, diagnostics, supportive care, and public-health surveillance. Sustained progress requires closing coverage and access gaps while responding to changing serotypes and resistance patterns. Regional and country strategies should be adapted to local epidemiology and health-system capacity, supported by reliable data and clinically validated digital tools. Leaders that connect prevention with rapid, evidence-based treatment will be better positioned to reduce severe disease, complications, and avoidable antimicrobial exposure.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Pediatrics Pneumococcal Therapeutics Market, by Product
7.1. Introduction
7.2. Drug
7.3. Vaccine
7.3.1. Conjugate Vaccine
7.3.2. Polysaccharide Vaccine
8. Pediatrics Pneumococcal Therapeutics Market, by Age Group
8.1. Introduction
8.2. Infants
8.3. Toddlers
9. Pediatrics Pneumococcal Therapeutics Market, by Disease Type
9.1. Introduction
9.2. Bacterial Pneumonia
9.3. Mycoplasma Pneumonia
9.4. Viral Pneumonia
10. Pediatrics Pneumococcal Therapeutics Market, by Mode of Administration
10.1. Introduction
10.2. Intramuscular
10.3. Intranasal
10.4. Intravenous
10.5. Oral
11. Pediatrics Pneumococcal Therapeutics Market, by Therapeutic Applications
11.1. Introduction
11.2. Invasive Pneumococcal Diseases
11.2.1. Bacteremia
11.2.2. Meningitis
11.3. Non-Invasive Pneumococcal Diseases
11.3.1. Otitis Media
11.3.2. Sinusitis
12. Pediatrics Pneumococcal Therapeutics Market, by End-User
12.1. Introduction
12.2. Clinics
12.3. Homecare Settings
12.4. Hospitals
13. Pediatrics Pneumococcal Therapeutics Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Pediatrics Pneumococcal Therapeutics Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Pediatrics Pneumococcal Therapeutics Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. AbbVie Inc.
17.2. Astellas Pharma Inc.
17.3. Aurobindo Pharma Limited
17.4. Baxter International Inc.
17.5. Biocon Limited
17.6. CanSino Biologics Inc.
17.7. Daiichi Sankyo Company, Limited
17.8. Dr. Reddy's Laboratories Ltd.
17.9. GlaxoSmithKline plc
17.10. Hoffmann-La Roche AG
17.11. Lupin Limited
17.12. Merck & Co., Inc
17.13. Novartis AG
17.14. Pfizer Inc.
17.15. Sanofi S.A.
17.16. Serum Institute of India Pvt. Ltd
17.17. Sinovac Biotech Ltd.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Pediatrics Pneumococcal Therapeutics Market, Years Considered for the Study
FIGURE 2. Global Pediatrics Pneumococcal Therapeutics Market, Research Design
FIGURE 3. Global Pediatrics Pneumococcal Therapeutics Market, Research Framework
FIGURE 4. Global Pediatrics Pneumococcal Therapeutics Market, Data Triangulation
FIGURE 5. Global Pediatrics Pneumococcal Therapeutics Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2025 vs 2032 (%)
FIGURE 7. Global Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2025 vs 2032 (%)
FIGURE 9. Global Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2025 vs 2032 (%)
FIGURE 11. Global Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2025 vs 2032 (%)
FIGURE 13. Global Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2025 vs 2032 (%)
FIGURE 15. Global Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 17. Global Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Pediatrics Pneumococcal Therapeutics Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Pediatrics Pneumococcal Therapeutics Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Pediatrics Pneumococcal Therapeutics Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Pediatrics Pneumococcal Therapeutics Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Pediatrics Pneumococcal Therapeutics Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Pediatrics Pneumococcal Therapeutics Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Pediatrics Pneumococcal Therapeutics Market Segmentation & Coverage
TABLE 2. Global Pediatrics Pneumococcal Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 3. Global Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 4. Global Drug Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Drug Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Drug Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Conjugate Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Conjugate Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Conjugate Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Polysaccharide Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Polysaccharide Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Polysaccharide Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 17. Global Infants Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Infants Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Infants Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Toddlers Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Toddlers Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Toddlers Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 24. Global Bacterial Pneumonia Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Bacterial Pneumonia Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Bacterial Pneumonia Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Mycoplasma Pneumonia Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Mycoplasma Pneumonia Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Mycoplasma Pneumonia Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Viral Pneumonia Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Viral Pneumonia Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Viral Pneumonia Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 34. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Intranasal Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Intranasal Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Intranasal Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 47. Global Invasive Pneumococcal Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Invasive Pneumococcal Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Invasive Pneumococcal Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Bacteremia Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Bacteremia Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Bacteremia Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Meningitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Meningitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Meningitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Non-Invasive Pneumococcal Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Non-Invasive Pneumococcal Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Non-Invasive Pneumococcal Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Otitis Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Otitis Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Otitis Media Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Sinusitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Sinusitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Sinusitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 66. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Homecare Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Homecare Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Homecare Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Pediatrics Pneumococcal Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Pediatrics Pneumococcal Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 86. North America Pediatrics Pneumococcal Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. North America Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 88. North America Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 89. North America Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 90. North America Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 91. North America Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 92. North America Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 93. North America Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 94. North America Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 95. North America Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 96. Latin America Pediatrics Pneumococcal Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Latin America Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 98. Latin America Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 99. Latin America Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 100. Latin America Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 101. Latin America Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 102. Latin America Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 103. Latin America Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 104. Latin America Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 105. Latin America Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 106. Europe Pediatrics Pneumococcal Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Europe Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 108. Europe Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 109. Europe Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 110. Europe Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 111. Europe Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 112. Europe Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 113. Europe Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 114. Europe Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 115. Europe Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 116. Middle East Pediatrics Pneumococcal Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Middle East Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 118. Middle East Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 119. Middle East Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 120. Middle East Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 121. Middle East Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 122. Middle East Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 123. Middle East Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 124. Middle East Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 125. Middle East Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 126. Africa Pediatrics Pneumococcal Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Africa Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 128. Africa Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 129. Africa Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 130. Africa Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 131. Africa Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 132. Africa Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 133. Africa Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 134. Africa Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 135. Africa Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 136. Global Pediatrics Pneumococcal Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. ASEAN Pediatrics Pneumococcal Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. ASEAN Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 139. ASEAN Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 140. ASEAN Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 141. ASEAN Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 142. ASEAN Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 143. ASEAN Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 144. ASEAN Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 145. ASEAN Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 146. ASEAN Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 147. GCC Pediatrics Pneumococcal Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. GCC Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 149. GCC Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 150. GCC Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 151. GCC Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 152. GCC Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 153. GCC Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 154. GCC Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 155. GCC Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 156. GCC Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 157. European Union Pediatrics Pneumococcal Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. European Union Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 159. European Union Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 160. European Union Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 161. European Union Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 162. European Union Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 163. European Union Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 164. European Union Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 165. European Union Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 166. European Union Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 167. BRICS Pediatrics Pneumococcal Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. BRICS Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 169. BRICS Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 170. BRICS Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 171. BRICS Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 172. BRICS Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 173. BRICS Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 174. BRICS Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 175. BRICS Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 176. BRICS Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 177. G7 Pediatrics Pneumococcal Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. G7 Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 179. G7 Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 180. G7 Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 181. G7 Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 182. G7 Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 183. G7 Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 184. G7 Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 185. G7 Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 186. G7 Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 187. NATO Pediatrics Pneumococcal Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. NATO Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 189. NATO Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 190. NATO Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 191. NATO Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 192. NATO Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 193. NATO Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 194. NATO Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 195. NATO Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 196. NATO Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 197. Global Pediatrics Pneumococcal Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 198. United States Pediatrics Pneumococcal Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 199. United States Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 200. United States Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 201. United States Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 202. United States Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 203. United States Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 204. United States Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 205. United States Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 206. United States Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 207. United States Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 208. Canada Pediatrics Pneumococcal Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 209. Canada Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 210. Canada Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 211. Canada Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 212. Canada Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 213. Canada Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 214. Canada Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 215. Canada Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 216. Canada Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 217. Canada Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 218. Mexico Pediatrics Pneumococcal Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 219. Mexico Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 220. Mexico Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 221. Mexico Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 222. Mexico Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 223. Mexico Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 224. Mexico Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 225. Mexico Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 226. Mexico Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 227. Mexico Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 228. Brazil Pediatrics Pneumococcal Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 229. Brazil Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 230. Brazil Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 231. Brazil Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 232. Brazil Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 233. Brazil Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 234. Brazil Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 235. Brazil Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 236. Brazil Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 237. Brazil Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 238. United Kingdom Pediatrics Pneumococcal Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 239. United Kingdom Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 240. United Kingdom Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 241. United Kingdom Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 242. United Kingdom Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 243. United Kingdom Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 244. United Kingdom Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 245. United Kingdom Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 246. United Kingdom Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 247. United Kingdom Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 248. Germany Pediatrics Pneumococcal Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 249. Germany Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 250. Germany Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 251. Germany Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 252. Germany Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 253. Germany Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 254. Germany Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 255. Germany Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 256. Germany Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 257. Germany Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 258. France Pediatrics Pneumococcal Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 259. France Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 260. France Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 261. France Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 262. France Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 263. France Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 264. France Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 265. France Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 266. France Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 267. France Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 268. Russia Pediatrics Pneumococcal Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 269. Russia Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 270. Russia Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 271. Russia Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 272. Russia Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 273. Russia Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 274. Russia Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 275. Russia Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 276. Russia Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 277. Russia Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 278. Italy Pediatrics Pneumococcal Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 279. Italy Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 280. Italy Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 281. Italy Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 282. Italy Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 283. Italy Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 284. Italy Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 285. Italy Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 286. Italy Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 287. Italy Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 288. Spain Pediatrics Pneumococcal Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 289. Spain Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 290. Spain Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 291. Spain Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 292. Spain Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 293. Spain Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 294. Spain Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 295. Spain Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 296. Spain Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 297. Spain Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 298. China Pediatrics Pneumococcal Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 299. China Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 300. China Pediatrics Pneumococcal Therapeutics Market Size, by Vaccine, 2017-2032 (USD Million)
TABLE 301. China Pediatrics Pneumococcal Therapeutics Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 302. China Pediatrics Pneumococcal Therapeutics Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 303. China Pediatrics Pneumococcal Therapeutics Market Size, by Mode of Administration, 2017-2032 (USD Million)
TABLE 304. China Pediatrics Pneumococcal Therapeutics Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 305. China Pediatrics Pneumococcal Therapeutics Market Size, by Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 306. China Pediatrics Pneumococcal Therapeutics Market Size, by Non-Invasive Pneumococcal Diseases, 2017-2032 (USD Million)
TABLE 307. China Pediatrics Pneumococcal Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 308. India Pediatrics Pneumococcal Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 309. India Pediatrics Pneumococcal Therapeutics Market Size, by Product, 2017-2032 (USD Million)
TABLE 310. India Pediatrics Pne

Companies Mentioned

  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Aurobindo Pharma Limited
  • Baxter International Inc.
  • Biocon Limited
  • CanSino Biologics Inc.
  • Daiichi Sankyo Company, Limited
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline plc
  • Hoffmann-La Roche AG
  • Lupin Limited
  • Merck & Co., Inc
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd
  • Sinovac Biotech Ltd.

Related Topics

Related Reports

Pediatric Vaccines Market - Global Forecast 2026-2032 - Product Image

Pediatric Vaccines Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Pediatric Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Pediatric Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 116 Pages
  • Global
From
Pediatric Preventable Vaccine Market - Global Forecast 2026-2032 - Product Image

Pediatric Preventable Vaccine Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Pediatric Healthcare - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Pediatric Healthcare - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
Pediatric Epilepsy Therapeutics - Global Strategic Business Report - Product Image

Pediatric Epilepsy Therapeutics - Global Strategic Business Report

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.